Outcomes with durvalumab and savolitinib in metastatic papillary renal cancer (mPRC) according to international metastatic renal cell carcinoma database consortium (IMDC) risk groups
No Thumbnail Available
Identifiers
Date
2020-12-01
Authors
Choy, J.
Suarez Rodriguez, C.
Larkin, J.
Patel, P.
Perez Valderrama, B.
Rodriguez-Vida, A.
Glen, H.
Thistlethwaite, F.
Ralph, C.
Srinivasan, G.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
